Skip to main content

7 Result(s)

within Rosa Ruchlemer Remove this filter

and

  1. Article

    Open Access

    COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of ...

    Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò… in Leukemia (2021)

    Download PDF (1622 KB) View Article

  2. No Access

    Article

    Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia

    Pseudohyperkalemia, a false elevation of potassium level in vitro, can be observed in chronic lymphocytic leukemia (CLL) patients due to fragility of leukocytes along with a high leukocyte count. This retrospe...

    Alon Bnaya, Rosa Ruchlemer, Eyal Itzkowitz… in International Journal of Hematology (2021)

  3. Article

    COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

    Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by immunodeficiency. Hence, patients with CLL might be considered more susceptible to severe complications from COVID-19. We undert...

    Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini… in Leukemia (2020)

    Download PDF (1259 KB) View Article

  4. No Access

    Article

    Bone loss and hematological malignancies in adults: a pilot study

    Bone loss—osteopenia and osteoporosis—is a recognized consequence of solid tumors in adults, of pediatric hematological malignancies, and of the treatment for these diseases, but little research has been publi...

    Rosa Ruchlemer, Michal Amit-Kohn, Ariella Tvito… in Supportive Care in Cancer (2018)

  5. No Access

    Article

    Inhaled medicinal cannabis and the immunocompromised patient

    Medicinal cannabis is an invaluable adjunct therapy for pain relief, nausea, anorexia, and mood modification in cancer patients and is available as cookies or cakes, as sublingual drops, as a vaporized mist, o...

    Rosa Ruchlemer, Michal Amit-Kohn, David Raveh, Lumír Hanuš in Supportive Care in Cancer (2015)

  6. No Access

    Article

    Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients

    Using the database of the Israeli CLL Study Group, we investigated the incidence and prognostic significance of CD25 expression on the surface of lymphocytic leukemia cells. Strong CD25 expression was found in...

    Lev Shvidel, Andrei Braester, Osnat Bairey, Naomi Rahimi-Levene… in Annals of Hematology (2012)

  7. No Access

    Article

    Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study

    Although the incidence of chronic lymphocytic leukemia (CLL) increases exponentially with age, data on patients 80 years or older at diagnosis are sparse. The records of patients diagnosed with CLL at age ≥80 ...

    Osnat Bairey, Rosa Ruchlemer, Neomy Rahimi-Levene, Yair Herishanu… in Annals of Hematology (2011)